StockData
IDEXX Laboratories Inc logo

IDEXX Laboratories Inc (IDXX) stock

IDXXNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 2, 2026Score 19/3036% above fair value
$690.24−10.41 (-1.49%)

Close on Nov 17, 2026Market cap $54.38BP/E 48.5Yield –

IDEXX Laboratories EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

IDEXX Laboratories's EV/EBITDA was 34.5× on Nov 11, 2026, against 41.9× a year earlier. Over the last 5 years it ranged from 25.7× to 55.5×, with a median of 34.1×.

EV/EBITDA at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202634.5×−3.1
2025Dec 31, 202537.6×+10.0
2024Dec 31, 202427.7×−11.4
2023Dec 29, 202339.0×+3.9
2022Dec 30, 202235.1×−20.4
2021Dec 31, 202155.5×−4.8
2020Dec 31, 202060.3×+25.3
2019Dec 31, 201935.0×+6.4
2018Dec 31, 201828.6×+0.3
2017Dec 29, 201728.3×+3.1
2016Dec 30, 201625.2×+6.3
2015Dec 31, 201518.8×−2.6
2014Dec 31, 201421.5×+4.3
2013Dec 31, 201317.2×+0.8
2012Dec 31, 201216.4×+0.8
2011Dec 30, 201115.6×−0.9
2010Dec 31, 201016.4×+1.7
2009Dec 31, 200914.7×–

More IDEXX Laboratories figures

See a number that looks wrong?